These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7857713)

  • 1. Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines.
    Fischer JR; Darjes H; Lahm H; Schindel M; Drings P; Krammer PH
    Eur J Cancer; 1994; 30A(14):2125-9. PubMed ID: 7857713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective suppression of cytokine secretion in patients with small-cell lung cancer.
    Fischer JR; Schindel M; Stein N; Lahm H; Gallati H; Krammer PH; Drings P
    Ann Oncol; 1995 Nov; 6(9):921-6. PubMed ID: 8624296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
    Jakowlew SB; Mathias A; Chung P; Moody TW
    Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.
    Damstrup L; Rygaard K; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1993 May; 67(5):1015-21. PubMed ID: 8388229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
    J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of differentiation markers can accompany laminin-induced attachment of small cell lung cancer cells.
    Giaccone G; Broers J; Jensen S; Fridman RI; Linnoila R; Gazdar AF
    Br J Cancer; 1992 Sep; 66(3):488-95. PubMed ID: 1325826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer.
    Meazza R; Marciano S; Sforzini S; Orengo AM; Coppolecchia M; Musiani P; Ardizzoni A; Santi L; Azzarone B; Ferrini S
    Br J Cancer; 1996 Sep; 74(5):788-95. PubMed ID: 8795583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 1 integrin expression on human small cell lung cancer cells.
    Feldman LE; Shin KC; Natale RB; Todd RF
    Cancer Res; 1991 Feb; 51(4):1065-70. PubMed ID: 1705164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer.
    Fischer JR; Schindel M; Bülzebruck H; Lahm H; Krammer PH; Drings P
    Ann Oncol; 1997 May; 8(5):457-61. PubMed ID: 9233525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.
    Nørgaard P; Damstrup L; Rygaard K; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1994 May; 69(5):802-8. PubMed ID: 8180008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes.
    Cook G; Campbell JD; Carr CE; Boyd KS; Franklin IM
    J Leukoc Biol; 1999 Dec; 66(6):981-8. PubMed ID: 10614781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High value of the radiobiological parameter Dq correlates to expression of the transforming growth factor beta type II receptor in a panel of small cell lung cancer cell lines.
    Hougaard S; Krarup M; Nørgaard P; Damstrup L; Spang-Thomsen M; Poulsen HS
    Lung Cancer; 1998 Apr; 20(1):65-9. PubMed ID: 9699189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines.
    Verbeeck MA; Elands JP; de Leij LF; Buys CH; Carney DN; Bepler G; Roebroeck AJ; Van de Ven WJ; Burbach JP
    Pathobiology; 1992; 60(3):136-42. PubMed ID: 1320893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.
    Lahm H; Petral-Malec D; Yilmaz-Ceyhan A; Fischer JR; Lorenzoni M; Givel JC; Odartchenko N
    Eur J Cancer; 1992; 28A(11):1894-9. PubMed ID: 1389533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
    Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
    Fridman R; Giaccone G; Kanemoto T; Martin GR; Gazdar AF; Mulshine JL
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6698-702. PubMed ID: 2168554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
    de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M
    Oncol Res; 1997; 9(2):89-98. PubMed ID: 9167190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.